Novo Nordisk’s Wegovy Weight Loss Shot Approved at Higher Dose in EU - The Wall Street Journal
Novo Nordisk’s Wegovy Weight Loss Shot Approved at Higher Dose in EU The Wall Street Journal
Novo Nordisk’s Wegovy Weight Loss Shot Approved at Higher Dose in EU The Wall Street Journal
Dr Reddy’s says Wegovy copycat to be priced competitively, with 50–60% discounts feasible Reuters
EU approves higher dose of Novo Nordisk's Wegovy Reuters
Drugs Behind Ozempic and Wegovy Are Being Repurposed — Here Are 5 Others Discover Magazine
Novo wins EU approval for higher-dose Wegovy (NVO:NYSE) Seeking Alpha
Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America PR Newswire
New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound Scientific American
Wegovy maker sues rival over 'knock-off' weight-loss drugs BBC
Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill USA Today
UK Warns of Pancreatitis, Deaths Tied to Wegovy, Mounjaro Bloomberg
Recon: Danaher to purchase Masimo for $9.9B; EU authorizes higher dose of Novo’s Wegovy Regulatory Affairs Professionals Society | RAPS
Oral Ozempic & Wegovy: The Future of Weight Loss Treatment HCPLive
Much Bigger Wegovy Dose Approved By EU Forbes
EU approves Novo Nordisk's high-dose version of Wegovy medwatch.com
European Commission Approves 7.2 mg Once-Weekly Wegovy Dose for Adults With Obesity BioPharm International
Weight loss drug scams surge nationwide FOX 8 News
Hims & Hers launches Wegovy knockoff pill, drugmaker Novo Nordisk vows to sue PBS
Weight-loss race: how switch from injections to pills is expanding big pharma’s hopes The Guardian
Amid Wegovy pill's flying start in US, Novo CEO eyes Ireland expansion for supply overseas: Bloomberg Fierce Pharma
Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers' hands PR Newswire
Novo Set to Make Wegovy Pill in Ireland for Markets Outside US Bloomberg
Novo to Follow Lilly and Sell Obesity Shot Wegovy in Vials Bloomberg
US could take action including fines against Hims after brief Wegovy copy launch Reuters
Novo's Wegovy pill tracks over 38,000 prescriptions in fifth week Reuters
Novo Nordisk plans to launch Wegovy vials Reuters
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows Reuters
European Commission approves higher dose of Wegovy PharmaLive
More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds Reuters
Wegovy pill in high demand in weeks since launch, Novo Nordisk says NBC News
Novo Nordisk faces copy competition in India: Dr. Reddy's set to launch Wegovy imitation medwatch.com
Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026 The Guardian
Novo Nordisk says it will take legal action after Hims & Hers reveals $49 copy of Wegovy pill CNBC
Wegovy Pill: What to Know About the New Oral Semaglutide for Weight Loss & Insulin Resistance Yahoo Creators
Wegovy maker warns price cuts 'painful' for firm as shares plunge BBC
Taking the new Wegovy pill every day is really complicated. Will patients stick with it? MarketWatch
Once-Daily Oral Wegovy Now Available for Weight Loss The Cardiology Advisor
Him & Hers plans to offer cheaper version of Wegovy pill, prompting Novo Nordisk to threaten legal action Fierce Healthcare
Oral Wegovy Brings in Thousands of New GLP-1 Patients BioSpace
The overlooked nutrition risk of Ozempic and Wegovy ScienceDaily
FDA Blocks Hims & Hers $49 Compounded Wegovy Pill: What to Know Healthline